Evidence map›Paper›PMID 24657592›Full record

ArticleBehavioural brain research2014

Impaired sensorimotor gating in Fmr1 knock out and Fragile X premutation model mice.

A J Renoux, K J Sala-Hamrick, N M Carducci, M Frazer, K E Halsey, M A Sutton, D F Dolan, G G Murphy, P K Todd

Open access · greenAbstract read
In one paragraph

Article in Behavioural brain research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

A J RenouxDepartment of Neurology, USA; Department of Molecular and Integrative Physiology, USA.
K J Sala-HamrickDepartment of Neurology, USA.
N M CarducciDepartment of Neurology, USA.
M FrazerDepartment of Neurology, USA.
K E HalseyKresge Hearing Research Institute, Department of Otolaryngology - Head and Neck Surgery, USA.
M A SuttonDepartment of Molecular and Integrative Physiology, USA; Molecular and Behavioral Neuroscience Institute, USA.
D F DolanKresge Hearing Research Institute, Department of Otolaryngology - Head and Neck Surgery, USA.
G G MurphyDepartment of Molecular and Integrative Physiology, USA; Molecular and Behavioral Neuroscience Institute, USA.
P K ToddDepartment of Neurology, USA. Electronic address: petertod@umich.edu.
Institute of Molecular Medicine · INKresge Eye Institute · USLaboratoire d’immunologie intégrative du cancer · FRSt Peter's Hospital · US

Funding

Scientific Synergy CoreP30DC005188 · NIDCD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALTSCHULER, RICHARD A · 2002 to 2016
$10.3M
CGG repeat associated translation in Fragile X-associated Tremor/Ataxia Syndrome-Diversity SupplementR01NS086810 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TODD, PETER K · 2014 to 2024
$4.1M
L-type Calcium Channels, Neuronal Excitability & Cognition in Aged MiceR01AG028488 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MURPHY, GEOFFREY G · 2008 to 2012
$1.5M
Pathogenic Mechanisms in Fragile X Tremor Ataxia SyndromeK08NS069809 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TODD, PETER K · 2010 to 2014
$877k
Neuronal dysfunction in fragile X spectrum disordersF31MH097451 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RENOUX, ABIGAIL · 2012 to 2014
$98k
Neuronal Dysfunction in Fragile X Tremor Ataxia SyndromeI01BX001689 · VA · VETERANS HEALTH ADMINISTRATION · PI TODD, PETER K · 2013 to 2016
–
BLRD VA I01 BX001689NIA NIH HHS R01 AG028488NIA NIH HHS R01AG028488NIDCD NIH HHS P30 DC005188NIDCD NIH HHS P30 DC05188NIMH NIH HHS F31 MH097451NIMH NIH HHS F31MH097451NINDS NIH HHS 1K08NS069809NINDS NIH HHS K08 NS069809NINDS NIH HHS R01 NS086810
6 · The paper itself

Abstract

Fragile X syndrome (FXS) is a common inherited cause of intellectual disability that results from a CGG repeat expansion in the FMR1 gene. Large repeat expansions trigger both transcriptional and translational suppression of Fragile X protein (FMRP) production. Fragile X-associated Tremor/Ataxia Syndrome (FXTAS) is an allelic neurodegenerative disease caused by smaller "pre-mutation" CGG repeat expansions that enhance FMR1 transcription but lead to translational inefficiency and reduced FMRP expression in animal models. Sensorimotor gating as measured by pre-pulse inhibition (PPI) is altered in both FXS patients and Fmr1 knock out (KO) mice. Similarly, FXTAS patients have demonstrated PPI deficits. Recent work suggests there may be overlapping synaptic defects between Fmr1 KO and CGG knock-in premutation mouse models (CGG KI). We therefore sought to interrogate PPI in CGG KI mice. Using a quiet PPI protocol more akin to human testing conditions, we find that Fmr1 KO animals have significantly impaired PPI. Using this same protocol, we find CGG KI mice demonstrate an age-dependent impairment in PPI compared to wild type (WT) controls. This study describes a novel phenotype in CGG KI mice that can be used in future therapeutic development targeting premutation associated symptoms.

Indexed as

Acoustic StimulationAge FactorsAnimalsAuditory PerceptionDisease Models, AnimalFragile X Messenger Ribonucleoprotein 1Fragile X SyndromeGene Knock-In TechniquesMaleMiceMice, Inbred C57BLMice, KnockoutPhenotypePrepulse InhibitionSensory GatingTrinucleotide Repeat ExpansionFmr1 protein, mouseFragile X Messenger Ribonucleoprotein 1Fragile XPremutation carrierPrepulse inhibitionSensorimotor gating

Identifiers

PMID24657592
PMCPMC4070219
OpenAlexW2054378265

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.